| Titre : | Malignant : How Bad Policy and bad Evidence Harm People with Cancer |
| Auteurs : | Vinayak K. Prasad |
| Type de document : | Ouvrage |
| Editeur : | Baltimore [USA] : Johns Hopkins University press, 2020 |
| ISBN : | 978-1-4214-3763-7 |
| Description : | 289p. / index |
| Langues: | Anglais |
| Classement : | FR82/ (CANCER) |
| Mots-clés : | MEDECINE BASEE SUR LES PREUVES ; Conflit d'intérêt ; Donnée probante ; Médecine fondée sur les preuves ; Conflit d'intérêts ; Politique santé ; Recherche médicale ; Prix ; Médicament ; Groupe pression ; Médicament anticancéreux ; Recherche pharmaceutique ; Innovation technologique ; Etude critique |
| Résumé : | Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel―but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration. |
Exemplaires (1)
| Code-barres | Cote | Support | Localisation | Section | Disponibilité |
|---|---|---|---|---|---|
| 095570 | FR82/0285 | Ouvrage | Rennes | Salle Belle-Île | Empruntable Disponible |